Effects of Aerosol Corticosteroids on the Voice Triamcinolone Acetonide and Beclomethasone Dipropionate Research Note
Research Note  |   June 01, 1985
Effects of Aerosol Corticosteroids on the Voice
 
Author Affiliations & Notes
  • Kenneth L. Watkin
    University of Michigan, Ann Arbor
  • Stanley J. Ewanowski
    University of Wisconsin, Madison
Article Information
Research Notes
Research Note   |   June 01, 1985
Effects of Aerosol Corticosteroids on the Voice
Journal of Speech, Language, and Hearing Research, June 1985, Vol. 28, 301-304. doi:10.1044/jshr.2802.301
History: Received November 2, 1982 , Accepted October 10, 1984
 
Journal of Speech, Language, and Hearing Research, June 1985, Vol. 28, 301-304. doi:10.1044/jshr.2802.301
History: Received November 2, 1982; Accepted October 10, 1984

The present investigation compared the effects of triamcinolone acetonide (Aristocort® Aerosol) and beclomethasone dipropionate (Vanceril Inhaler®) on the vocal functioning of 11 chronic asthmatics. Using conventional aero-acoustic techniques, subjects' vocal fundamental frequency, maximum phonation time, and oral air volume velocity were sampled at baseline (oral corticosteroid use) and at the end of the first and second year of aerosol triamcinolone acetonide use. At the end of the second year of aerosol triamcinolone acetonide use, all subjects discontinued use of this compound and began use of aerosol beclomethasone dipropionate. Subjects' vocal performance then was sampled after 1 year of aerosol beclomethasone dipropionate use. Results of this study suggest that aerosol triamcinolone acetonide reduced the vocal dysfunction observed during the baseline period. When aerosol beclomethasone dipropionate was used, however, subjects' vocal performance was similar to that observed during the baseline period (oral steroid use).

Order a Subscription
Pay Per View
Entire Journal of Speech, Language, and Hearing Research content & archive
24-hour access
This Article
24-hour access